Nadav Kidron - Nov 7, 2024 Form 4 Insider Report for ORAMED PHARMACEUTICALS INC. (ORMP)

Role
President and CEO, Director
Signature
/s/ Nadav Kidron
Stock symbol
ORMP
Transactions as of
Nov 7, 2024
Transactions value $
$0
Form type
4
Date filed
11/8/2024, 04:30 PM
Previous filing
Jan 8, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ORMP Common Stock Award +45K +2.53% 1.83M Nov 7, 2024 Direct F1
holding ORMP Common Stock 126K Nov 7, 2024 By wholly-owned corporation
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents Restricted Stock Units ("RSUs") that will vest on November 7, 2024. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.